Trial Profile
Time to Thrombocytic Inhibition After Supine and Upright Ingestion of Efient
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Oct 2017
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary)
- Indications Acute coronary syndromes; Myocardial infarction; Thrombosis
- Focus Pharmacodynamics
- Acronyms TTISUE
- 09 Apr 2016 According to ClinicalTrials.gov record,study design is changed from non-randomised to randomised and treatment arms changed from 1 to 2.
- 09 Apr 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 24 Oct 2013 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.